Skylands Capital LLC 13D and 13G filings for Cytosorbents Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 2:22 pm Purchase | 2025-03-31 | 13G | Cytosorbents Corporation CTSO | Skylands Capital LLC | 3,002,702 4.800% | 221,080 (+7.95%) | Filing |
| 2025-01-07 1:26 pm Sale | 2024-12-31 | 13G | Cytosorbents Corporation CTSO | Skylands Capital LLC | 2,781,622 5.100% | -472,591 (-14.52%) | Filing |
| 2024-01-08 3:00 pm Purchase | 2023-12-31 | 13G | Cytosorbents Corporation CTSO | Skylands Capital LLC | 3,254,213 7.300% | 712,122 (+28.01%) | Filing |
| 2023-02-07 2:28 pm Purchase | 2022-12-31 | 13G | Cytosorbents Corporation CTSO | Skylands Capital LLC | 2,542,091 5.800% | 2,542,091 (New Position) | Filing |